A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Duloxetine | The risk or severity of orthostatic hypotension and syncope can be increased when Diclofenamide is combined with Duloxetine. |
| Levodopa | The risk or severity of hypotension and orthostatic hypotension can be increased when Diclofenamide is combined with Levodopa. |
| Risperidone | Diclofenamide may increase the hypotensive activities of Risperidone. |
| Nicotine | The risk or severity of adverse effects can be increased when Diclofenamide is combined with Nicotine. |
| Mecamylamine | The risk or severity of adverse effects can be increased when Diclofenamide is combined with Mecamylamine. |
| Pentolinium | The risk or severity of adverse effects can be increased when Diclofenamide is combined with Pentolinium. |
| Trimethaphan | The risk or severity of adverse effects can be increased when Diclofenamide is combined with Trimethaphan. |
| Hexamethonium | The risk or severity of adverse effects can be increased when Diclofenamide is combined with Hexamethonium. |
| Cyclopentamine | The risk or severity of adverse effects can be increased when Diclofenamide is combined with Cyclopentamine. |
| Flecainide | The excretion of Flecainide can be decreased when combined with Diclofenamide. |
| Memantine | The excretion of Memantine can be decreased when combined with Diclofenamide. |
| Quinine | The excretion of Quinine can be decreased when combined with Diclofenamide. |
| Quinidine | The excretion of Quinidine can be decreased when combined with Diclofenamide. |
| Methotrexate | The protein binding of Methotrexate can be increased when combined with Diclofenamide. |
| Lithium hydroxide | The excretion of Lithium hydroxide can be increased when combined with Diclofenamide. |
| Lithium citrate | The excretion of Lithium citrate can be increased when combined with Diclofenamide. |
| Metformin | The risk or severity of lactic acidosis can be increased when Diclofenamide is combined with Metformin. |
| Aripiprazole | Aripiprazole may increase the hypotensive activities of Diclofenamide. |
| Aripiprazole lauroxil | Aripiprazole lauroxil may increase the hypotensive activities of Diclofenamide. |
| Nicorandil | Nicorandil may increase the hypotensive activities of Diclofenamide. |
| Dexketoprofen | The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Diclofenamide. |
| Ketoprofen | The risk or severity of adverse effects can be increased when Ketoprofen is combined with Diclofenamide. |
| Methenamine | The serum concentration of the active metabolites of Methenamine can be reduced when Methenamine is used in combination with Diclofenamide resulting in a loss in efficacy. |
| Cyclosporine | The risk or severity of renal failure can be increased when Diclofenamide is combined with Cyclosporine. |
| Triethylenetetramine | The excretion of Triethylenetetramine can be increased when combined with Diclofenamide. |
| Linezolid | Linezolid may increase the orthostatic hypotensive activities of Diclofenamide. |
| Furazolidone | Furazolidone may increase the orthostatic hypotensive activities of Diclofenamide. |
| Procaine | Procaine may increase the orthostatic hypotensive activities of Diclofenamide. |
| Tranylcypromine | Tranylcypromine may increase the orthostatic hypotensive activities of Diclofenamide. |
| Phenelzine | Phenelzine may increase the orthostatic hypotensive activities of Diclofenamide. |
| Minaprine | Minaprine may increase the orthostatic hypotensive activities of Diclofenamide. |
| Selegiline | Selegiline may increase the orthostatic hypotensive activities of Diclofenamide. |
| Procarbazine | Procarbazine may increase the orthostatic hypotensive activities of Diclofenamide. |
| Moclobemide | Moclobemide may increase the orthostatic hypotensive activities of Diclofenamide. |
| Isocarboxazid | Isocarboxazid may increase the orthostatic hypotensive activities of Diclofenamide. |
| Rasagiline | Rasagiline may increase the orthostatic hypotensive activities of Diclofenamide. |
| Pargyline | Pargyline may increase the orthostatic hypotensive activities of Diclofenamide. |
| Clorgiline | Clorgiline may increase the orthostatic hypotensive activities of Diclofenamide. |
| Iproniazid | Iproniazid may increase the orthostatic hypotensive activities of Diclofenamide. |
| Nialamide | Nialamide may increase the orthostatic hypotensive activities of Diclofenamide. |
| Safinamide | Safinamide may increase the orthostatic hypotensive activities of Diclofenamide. |
| 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline | 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Diclofenamide. |
| Methylene blue | Methylene blue may increase the orthostatic hypotensive activities of Diclofenamide. |
| Hydracarbazine | Hydracarbazine may increase the orthostatic hypotensive activities of Diclofenamide. |
| Pirlindole | Pirlindole may increase the orthostatic hypotensive activities of Diclofenamide. |
| Toloxatone | Toloxatone may increase the orthostatic hypotensive activities of Diclofenamide. |
| Benmoxin | Benmoxin may increase the orthostatic hypotensive activities of Diclofenamide. |
| Mebanazine | Mebanazine may increase the orthostatic hypotensive activities of Diclofenamide. |
| Octamoxin | Octamoxin may increase the orthostatic hypotensive activities of Diclofenamide. |
| Pheniprazine | Pheniprazine may increase the orthostatic hypotensive activities of Diclofenamide. |
| Phenoxypropazine | Phenoxypropazine may increase the orthostatic hypotensive activities of Diclofenamide. |
| Pivhydrazine | Pivhydrazine may increase the orthostatic hypotensive activities of Diclofenamide. |
| Safrazine | Safrazine may increase the orthostatic hypotensive activities of Diclofenamide. |
| Caroxazone | Caroxazone may increase the orthostatic hypotensive activities of Diclofenamide. |
| Harmaline | Harmaline may increase the orthostatic hypotensive activities of Diclofenamide. |
| Brofaromine | Brofaromine may increase the orthostatic hypotensive activities of Diclofenamide. |
| Butalbital | Butalbital may increase the hypotensive activities of Diclofenamide. |
| Pentobarbital | Pentobarbital may increase the hypotensive activities of Diclofenamide. |
| Secobarbital | Secobarbital may increase the hypotensive activities of Diclofenamide. |
| Methohexital | Methohexital may increase the hypotensive activities of Diclofenamide. |
| Thiopental | Thiopental may increase the hypotensive activities of Diclofenamide. |
| Primidone | Primidone may increase the hypotensive activities of Diclofenamide. |
| Methylphenobarbital | Methylphenobarbital may increase the hypotensive activities of Diclofenamide. |
| Thiamylal | Thiamylal may increase the hypotensive activities of Diclofenamide. |
| Phenobarbital | Phenobarbital may increase the hypotensive activities of Diclofenamide. |
| Amobarbital | Amobarbital may increase the hypotensive activities of Diclofenamide. |
| Hexobarbital | Hexobarbital may increase the hypotensive activities of Diclofenamide. |
| Barbital | Barbital may increase the hypotensive activities of Diclofenamide. |
| Barbexaclone | Barbexaclone may increase the hypotensive activities of Diclofenamide. |
| Aminosalicylic acid | The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Diclofenamide. |
| Mesalazine | The risk or severity of adverse effects can be increased when Mesalazine is combined with Diclofenamide. |
| Sulfasalazine | The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Diclofenamide. |
| Diflunisal | The risk or severity of adverse effects can be increased when Diflunisal is combined with Diclofenamide. |
| Salicylic acid | The risk or severity of adverse effects can be increased when Salicylic acid is combined with Diclofenamide. |
| Balsalazide | The risk or severity of adverse effects can be increased when Balsalazide is combined with Diclofenamide. |
| Olsalazine | The risk or severity of adverse effects can be increased when Olsalazine is combined with Diclofenamide. |
| Bismuth subsalicylate | The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Diclofenamide. |
| Dersalazine | The risk or severity of adverse effects can be increased when Dersalazine is combined with Diclofenamide. |
| Phenyl aminosalicylate | The risk or severity of adverse effects can be increased when Phenyl aminosalicylate is combined with Diclofenamide. |
| Methyl salicylate | The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Diclofenamide. |
| Nitroaspirin | The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Diclofenamide. |
| Aloxiprin | The risk or severity of adverse effects can be increased when Aloxiprin is combined with Diclofenamide. |
| Guacetisal | The risk or severity of adverse effects can be increased when Guacetisal is combined with Diclofenamide. |
| Carbaspirin calcium | The risk or severity of adverse effects can be increased when Carbaspirin calcium is combined with Diclofenamide. |
| Choline salicylate | The risk or severity of adverse effects can be increased when Choline salicylate is combined with Diclofenamide. |
| Thiosalicylic acid | The risk or severity of adverse effects can be increased when Thiosalicylic acid is combined with Diclofenamide. |
| Phenytoin | The risk or severity of osteomalacia can be increased when Diclofenamide is combined with Phenytoin. |
| Fosphenytoin | The risk or severity of osteomalacia can be increased when Diclofenamide is combined with Fosphenytoin. |
| Ethoxzolamide | The risk or severity of adverse effects can be increased when Ethoxzolamide is combined with Diclofenamide. |
| Methazolamide | The risk or severity of adverse effects can be increased when Methazolamide is combined with Diclofenamide. |
| Acetazolamide | The risk or severity of adverse effects can be increased when Acetazolamide is combined with Diclofenamide. |
| Zonisamide | The risk or severity of adverse effects can be increased when Zonisamide is combined with Diclofenamide. |
| Phentermine | Diclofenamide may decrease the excretion rate of Phentermine which could result in a higher serum level. |
| Pseudoephedrine | Diclofenamide may decrease the excretion rate of Pseudoephedrine which could result in a higher serum level. |
| Benzphetamine | Diclofenamide may decrease the excretion rate of Benzphetamine which could result in a higher serum level. |
| Diethylpropion | Diclofenamide may decrease the excretion rate of Diethylpropion which could result in a higher serum level. |
| Lisdexamfetamine | Diclofenamide may decrease the excretion rate of Lisdexamfetamine which could result in a higher serum level. |
| Mephentermine | Diclofenamide may decrease the excretion rate of Mephentermine which could result in a higher serum level. |
| MMDA | Diclofenamide may decrease the excretion rate of MMDA which could result in a higher serum level. |
| Midomafetamine | Diclofenamide may decrease the excretion rate of Midomafetamine which could result in a higher serum level. |